April 27, 2004

FOR: ZOLL Medical Corporation

INVESTOR CONTACT: A. Ernest Whiton
Chief Financial Officer
ZOLL Medical Corporation
(978) 421-9655
PRESS CONTACT: Robert Minicucci
Corporate Communications Manager
ZOLL Medical Corporation
+1 (978) 421-9832
rminicucci@zoll.com



FOR IMMEDIATE RELEASE

ZOLL Wins World Class Service Excellence Award

Tuesday, April 27, 2004 – CHELMSFORD, MASS.—ZOLL Medical Corporation (NASDAQ: ZOLL), a manufacturer of non-invasive cardiac resuscitation devices, announced today that it has won a NorthFace ScoreBoard Award, presented by the Omega Management Group Corporation. The annual award is presented to companies that demonstrate exemplary customer service and exceed customer expectations. The service categories in which ZOLL was recognized in 2003 were technical support, order shipment, and depot repair.

“While providing excellent customer service is a goal of every product or service company, maintaining it over time is not an everyday occurrence,” said Richard A. Packer, President and Chief Executive Officer of ZOLL. “I am proud of the ZOLL employees whose continued diligence has helped to earn this well-deserved honor. It shows our commitment to enhancing our customers’ ability to save lives through cardiac resuscitation.”

To qualify for the NorthFace ScoreBoard Award, a company must meet four criteria: 1) senior management commitment to exceeding customer expectations; 2) customer satisfaction program that identifies and corrects customer problems; 3) measuring the level of customer satisfaction with product/service; and 4) achieving an overall score of 4.0 out of 5.0 for a year. In ZOLL’s case, Omega conducted quarterly telephone surveys with 100 customers to determine level of achievement and quantify results. Highlights from the ZOLL customer satisfaction surveys were as follows:

· 98% of customers responding to the technical support survey rated ZOLL as meeting or exceeding their expectations.
· 97% of customers who responded to the order/delivery survey rated ZOLL as meeting or exceeding their expectations.

About ZOLL Medical Corporation
ZOLL Medical Corporation (NASDAQ: ZOLL), with worldwide headquarters in Chelmsford, Massachusetts, manufactures, markets, and sells non-invasive cardiac resuscitation devices and software solutions. These solutions include pacing and defibrillation devices (ZOLL’s M Series™ and AED Plus™, and LIFECOR, Inc.’s LifeVest™ Wearable Defibrillator); circulatory assist devices (Advanced Circulatory Systems, Inc.’s ResQPOD™ Circulatory Enhancer and Revivant Corporation’s AutoPulse™); and a unique fluid resuscitation product called the Power Infuser®, manufactured by Infusion Dynamics, a division of ZOLL. These devices help health care professionals, emergency medical service providers, and first responders diagnose and treat cardiac arrest wherever it occurs. Through its subsidiary ZOLL Data Systems, ZOLL also designs and markets software that automates the collection and management of both clinical and non-clinical data.

ZOLL has sales operations in Australia, Austria, Canada, China, France, Germany, India, The Netherlands, Russia, the United Kingdom, and the United States, and business partners in all of the world’s major markets. For more information, visit www.zoll.com or call 978-421-9655.

Certain statements contained in this press release, including statements regarding the anticipated development of the Company’s business, our ability to differentiate our products from others on the market, and other statements contained herein regarding matters that are not historical facts, are "forward-looking" statements (as defined in the Private Securities Litigation Reform Act of 1995). Because such statements are subject to risks and uncertainties, actual results may differ materially from those expressed or implied by such forward-looking statements. Factors that could cause actual results to differ materially from those expressed or implied by such forward-looking statements include, but are not limited to, those factors discussed in the section entitled "Risk Factors" in the Company’s Quarterly Report on Form 10-Q filed with the SEC on February 18, 2004.

# # #

Copyright © 2004 ZOLL Medical Corporation. All rights reserved. 269 Mill Road, Chelmsford, MA 01824-4105. AED Plus, M Series, and ZOLL Data Systems are trademarks of ZOLL Medical Corporation. The LifeVest System is a trademark of LIFECOR, Inc. The ResQPOD is a trademark of Advanced Circulatory Systems, Inc. The AutoPulse Resuscitation System is a trademark of Revivant Corporation. Power Infuser is a registered trademark of Infusion Dynamics. ZOLL is a registered trademark of ZOLL Medical Corporation. All trademarks are property of their respective owners.